ArticleJournal of enzyme inhibition and medicinal chemistry2020

The intensification of anticancer activity of LFM-A13 by erythropoietin as a possible option for inhibition of breast cancer.

Dariusz Rozkiewicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.